Navigation Links
Independent Marketing Automation Software Expert gives Positive review on MindMatrix's platform, AMP
Date:1/18/2013

Pittsburgh, PA (PRWEB) January 18, 2013

Mindmatrix Inc., creator of AMP, Marketing Automation Software, recently received positive reviews from an independent expert in the marketing automation domain. David Raab’s blog post titled “MindMatrix Adds Sales Support to Marketing Automation,” posted on December 4, 2012, describes how MindMatrix adds sales-marketing alignment to standard marketing automation features. MindMatrix has nearly 250 clients with about 34,000 end-users.

Referring to the platform’s ability to add sales marketing alignment to more traditional marketing automation tools, Raab notes ” MindMatrix does a good job with these features. Content personalization is especially sophisticated, supporting dynamic content (i.e., conditional logic) within templates; drawing personalization variables from user, partner, contact, and other tables; and providing precise control over which content attributes can be edited by a salesperson or other end-user. Personalized output formats include not just email, but also Web pages, PowerPoint, and online or printed PDFs.”

According to CEO Harbinder Khera, “MindMatrix first developed marketing automation tools to serve the real estate industry, but AMP is tailored to meet the needs of a broad array of industries. Every industry’s pain points were considered in the design of this platform, in particular, manufacturing and retail service industries. We have also structured these tools to help small and home-based businesses. In short, these tools are needed everywhere, and AMP is certainly a vertical specialist.”

According to his blog, Customer Experience Matrix, David Raab, “is a long-time marketing technology consultant and analyst. The blog is named for the Customer Experience Matrix, a tool to visualize marketing and operational interactions between a company and its customers.”

About MindMatrix

For the past 14 years, MindMatrix, Inc. has focused on sales-marketing alignment for over 34,000 sales and marketing professionals worldwide. Unique to the industry, MindMatrix offers Next-Generation Marketing Automation software on a single unified platform for Sales and Marketing. Our solutions bring about a seamless integration of the two key functions, helping our clients derive the maximum benefit from their investment in sales and marketing.

Our product offerings for sales include on-demand sales materials creation, smart lead management, lead prospecting, and more. On the marketing front, our solutions cover demand generation, brand management, quality lead generation, lead nurturing, social media automation, lead scoring, and marketing materials creation across print and digital media.

Please click here to read full review. For more information, please visit the MindMatrix website at http://www.mindmatrix.net, or call directly at 412-381-0230.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10332722.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
2. China Integrated Energy Inc. Completes Independent Investigation
3. No on Prop. 37: French Rat Study Author Made Reporters Sign Confidentiality Agreements Prohibiting them from Consulting Independent Scientific Experts
4. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
5. New Organization Plans to Use Independent Peer Review to Put Millions of Hours Back into Research
6. GeneLink Marketing Efforts Poised to Show Results
7. Codexis Names Wes Bolsen VP and Chief Marketing Officer
8. Alchem International Opens Sales and Marketing Office in the U.S.
9. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
10. SiREM and Tersus Environmental Form Strategic Marketing Alliance
11. AMRI Strengthens Business Development and Marketing Groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
Breaking Biology News(10 mins):